Rep. Buddy Carter voted YES on 8 of 8 bills classified by an AI model as favoring his top donor sectors—Pharmaceuticals & Biotech and Retail & Consumer—placing him at #24 among House members for this voting pattern. He voted YES on HR3537-117, the "Accelerating Access to Critical Therapies for ALS Act," classified as favoring the pharmaceutical sector, and also voted YES on 4 of 5 bills classified as limiting those same sectors.

EXAMPLE VOTES BEHIND THE NUMBER
HR3537-117 — Accelerating Access to Critical Therapies for ALS Act
HR8454-117 — Medical Marijuana and Cannabidiol Research Expansion Act
S3580-117 — Ocean Shipping Reform Act of 2022
FOLLOW THE TRAIL
◈ Ask the Analyst about Earl L. "Buddy" Carter →How we built this: a statistical pattern surfaced from public records — FEC campaign finance, Senate/House Lobbying Disclosure Act filings, and Congress.gov. The donor concentration and the legislative action are concurrent facts; this does not imply contributions caused the action, that the member acted improperly, or that the bill specifically benefits the named sector. Generated September 7, 2026 · internal signal score 90/100.